INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "KLK2XCD3 ANTIBODY AND AN ANTI-CANCER AGENT FOR TREATING PROSTATE CANCER"

GENEVA, Nov. 5 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, PA 19044) filed a patent application (PCT/US2025/025377) for "KLK2XCD3 ANTIBODY AND AN ANTI-CANCER AGENT FOR TREATING PROSTATE CANCER" on Apr 18, 2025. With publication no. WO/2025/226541, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VILLALOBOS, Victor, Manuel (c/o Janssen Biotech, Inc.800/850 Ridgeview DriveHorsham, PA 19044), THAPER, Daksh (c/o Janssen Biotech, Inc.800/850 Ridgeview DriveHorsham, PA 19044), OYER, Halley, Mellor (c/o Janssen Biot...